|
1
|
TCG Crossover Management
Palo Alto,
California
|
$96.5M
|
+$80M
|
+5,673,078
|
New
|
|
|
2
|
RA Capital Management
Boston,
Massachusetts
|
$96.4M
|
–
|
–
|
–
|
|
|
3
|
FCPM III Services
Naarden,
Netherlands
|
$73.5M
|
+$7.05M
|
+500,000
|
+14%
|
|
|
4
|
|
$54.3M
|
+$15.5M
|
+1,097,953
|
+56%
|
|
|
5
|
Frazier Life Sciences Management
Palo Alto,
California
|
$45.4M
|
–
|
–
|
–
|
|
|
6
|
Caligan Partners
New York
|
$34.3M
|
+$14.1M
|
+999,999
|
+108%
|
|
|
7
|
Paradigm Biocapital Advisors
New York
|
$31.2M
|
–
|
–
|
–
|
|
|
8
|
Great Point Partners
Greenwich,
Connecticut
|
$31.2M
|
+$5.36M
|
+379,893
|
+28%
|
|
|
9
|
Fidelity Investments
Boston,
Massachusetts
|
$27.5M
|
-$13.9M
|
-986,500
|
-39%
|
|
|
10
|
Vanguard Capital Management
Malvern,
Pennsylvania
|
$25.6M
|
+$20.2M
|
+1,433,280
|
New
|
|
|
11
|
Marshall Wace
London,
United Kingdom
|
$20.6M
|
+$16.3M
|
+1,153,276
|
New
|
|
|
12
|
State Street
Boston,
Massachusetts
|
$20M
|
+$14.5M
|
+1,027,405
|
+1,128%
|
|
|
13
|
NEXTBio Capital Management
Menlo Park,
California
|
$17.8M
|
–
|
–
|
–
|
|
|
14
|
|
$14.2M
|
+$4.64M
|
+329,123
|
+71%
|
|
|
15
|
Logos Global Management
San Francisco,
California
|
$13.4M
|
+$9.17M
|
+650,000
|
+650%
|
|
|
16
|
Rosalind Advisors
Toronto,
Ontario, Canada
|
$12.5M
|
+$9.87M
|
+700,000
|
New
|
|
|
17
|
Boothbay Fund Management
New York
|
$9.91M
|
+$7.84M
|
+555,702
|
New
|
|
|
18
|
UBS Group
Zurich,
Switzerland
|
$8.71M
|
+$2.77M
|
+196,250
|
+67%
|
|
|
19
|
Braidwell
Stamford,
Connecticut
|
$8.33M
|
+$6.58M
|
+466,774
|
New
|
|
|
20
|
Geode Capital Management
Boston,
Massachusetts
|
$6.11M
|
+$2.21M
|
+156,765
|
+84%
|
|
|
21
|
Clearline Capital
New York
|
$5.82M
|
+$4.6M
|
+326,168
|
New
|
|
|
22
|
Sphera Funds Management
Tel Aviv,
Israel
|
$5.74M
|
-$1.25M
|
-88,500
|
-22%
|
|
|
23
|
Laurion Capital Management
New York
|
$5.69M
|
+$20.1K
|
+1,427
|
+0.4%
|
|
|
24
|
Propel Bio Management
Los Angeles,
California
|
$5.59M
|
+$4.44M
|
+314,543
|
New
|
|
|
25
|
|
$4.67M
|
+$1.64M
|
+116,251
|
+80%
|
|
